A Clonogenic Progenitor with Prominent Plasmacytoid Dendritic Cell Developmental Potential

Immunity

Volumn 38, Issue 5, 2013, Pages 943-957

  Onai, Nobuyuki ^a,b   Kurabayashi, Kazutaka ^a   Hosoi Amaike, Mayuka ^a   Toyama Sorimachi, Noriko ^c   Matsushima, Kouji ^b,d   Inaba, Kayo ^b,e   Ohteki, Toshiaki ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; COMMON DENDRITIC PROGENITOR; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; LYMPHOID PRIMED MULTIPOTENT PROGENITOR; MACROPHAGE AND DENDRITIC CELL PROGENITOR; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LYMPHOID PROGENITOR CELLS; LYMPHOPOIESIS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 84878177936     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.04.006     Document Type: Article

References (56)

1. + lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005, 121:295-306.
2. + dendritic cells. Blood 2003, 101:305-310.
3. Anderson K.L., Perkin H., Surh C.D., Venturini S., Maki R.A., Torbett B.E. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J.Immunol. 2000, 164:1855-1861.
4. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Brière F., Trinchieri G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001, 2:1144-1150.
5. 3CR1 in their response to inflammation. J.Exp. Med. 2009, 206:595-606.
6. Banchereau J., Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25:383-392.
7. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
8. Belz G.T., Nutt S.L. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 2012, 12:101-113.
9. Björck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001, 98:3520-3526.
10. Bogunovic M., Ginhoux F., Helft J., Shang L., Hashimoto D., Greter M., Liu K., Jakubzick C., Ingersoll M.A., Leboeuf M., et al. Origin of the lamina propria dendritic cell network. Immunity 2009, 31:513-525.
11. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999, 5:919-923.
12. Chen W., Antonenko S., Sederstrom J.M., Liang X., Chan A.S., Kanzler H., Blom B., Blazar B.R., Liu Y.J. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004, 103:2547-2553.
13. Cisse B., Caton M.L., Lehner M., Maeda T., Scheu S., Locksley R., Holmberg D., Zweier C., den Hollander N.S., Kant S.G., et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008, 135:37-48.
14. D'Amico A., Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J.Exp. Med. 2003, 198:293-303.
15. de Heer H.J., Hammad H., Soullié T., Hijdra D., Vos N., Willart M.A., Hoogsteden H.C., Lambrecht B.N. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J.Exp. Med. 2004, 200:89-98.
16. Edelson B.T., Kc W., Juang R., Kohyama M., Benoit L.A., Klekotka P.A., Moon C., Albring J.C., Ise W., Michael D.G., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells. J.Exp. Med. 2010, 207:823-836.
17. Fancke B., Suter M., Hochrein H., O'Keeffe M. M-CSF: a novel plasmacytoid and conventional dendritic cell poietin. Blood 2008, 111:150-159.
18. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., Cumano A., Geissmann F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
19. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
20. Ghosh H.S., Cisse B., Bunin A., Lewis K.L., Reizis B. Continuous expression of the transcription factor E2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 2010, 33:905-916.
21. Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8:594-606.
22. Ginhoux F., Liu K., Helft J., Bogunovic M., Greter M., Hashimoto D., Price J., Yin N., Bromberg J., Lira S.A., et al. The origin and development of nonlymphoid tissue CD103+ DCs. J.Exp. Med. 2009, 206:3115-3130.
23. Goubier A., Dubois B., Gheit H., Joubert G., Villard-Truc F., Asselin-Paturel C., Trinchieri G., Kaiserlian D. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008, 29:464-475.
24. Guerriero A., Langmuir P.B., Spain L.M., Scott E.W. PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 2000, 95:879-885.
25. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., Calderon B., Schraml B.U., Unanue E.R., Diamond M.S., et al. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic Tcell immunity. Science 2008, 322:1097-1100.
26. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function bytargeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000, 20:4106-4114.
27. Karsunky H., Merad M., Cozzio A., Weissman I.L., Manz M.G. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells invivo. J.Exp. Med. 2003, 198:305-313.
28. Kushida T., Inaba M., Hisha H., Ichioka N., Esumi T., Ogawa R., Iida H., Ikehara S. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001, 97:3292-3299.
29. Kuwata N., Igarashi H., Ohmura T., Aizawa S., Sakaguchi N. Cutting edge: absence of expression of RAG1 in peritoneal B-1 cells detected by knocking into RAG1 locus with green fluorescent protein gene. J.Immunol. 1999, 163:6355-6359.
30. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23:275-306.
31. Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., Chu F.F., Randolph G.J., Rudensky A.Y., Nussenzweig M. Invivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
32. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., Maliszewski C.R., Lynch D.H., Smith J., Pulendran B., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000, 95:3489-3497.
33. Merad M., Manz M.G. Dendritic cell homeostasis. Blood 2009, 113:3418-3427.
34. Nagasawa M., Schmidlin H., Hazekamp M.G., Schotte R., Blom B. Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur. J. Immunol. 2008, 38:2389-2400.
35. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006, 7:663-671.
36. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., Carotta S., O'Keeffe M., Bahlo M., Papenfuss A., et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived invitro and invivo. Nat. Immunol. 2007, 8:1217-1226.
37. Nakano H., Yanagita M., Gunn M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J.Exp. Med. 2001, 194:1171-1178.
38. Onai N., Obata-Onai A., Tussiwand R., Lanzavecchia A., Manz M.G. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J.Exp. Med. 2006, 203:227-238.
39. Onai N., Obata-Onai A., Schmid M.A., Ohteki T., Jarrossay D., Manz M.G. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 2007, 8:1207-1216.
40. Ovchinnikov D.A., DeBats C.E., Sester D.P., Sweet M.J., Hume D.A. A conserved distal segment of the mouse CSF-1 receptor promoter is required for maximal expression of a reporter gene in macrophages and osteoclasts of transgenic mice. J.Leukoc. Biol. 2010, 87:815-822.
41. Pelayo R., Hirose J., Huang J., Garrett K.P., Delogu A., Busslinger M., Kincade P.W. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 2005, 105:4407-4415.
42. Reizis B. Regulation of plasmacytoid dendritic cell development. Curr.Opin. Immunol. 2010, 22:206-211.
43. Schiavoni G., Mattei F., Sestili P., Borghi P., Venditti M., Morse H.C., Belardelli F., Gabriele L. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8α(+) dendritic cells. J.Exp. Med. 2002, 196:1415-1425.
44. Schiavoni G., Mattei F., Borghi P., Sestili P., Venditti M., Morse H.C., Belardelli F., Gabriele L. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 2004, 103:2221-2228.
45. Schlitzer A., Loschko J., Mair K., Vogelmann R., Henkel L., Einwächter H., Schiemann M., Niess J.H., Reindl W., Krug A. Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs. Blood 2011, 117:6562-6570.
46. Schlitzer A., Heiseke A.F., Einwächter H., Reindl W., Schiemann M., Manta C.-P., See P., Niess J.H., Suter T., Ginhoux F., Krug A.B. Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor. Blood 2012, 119:6063-6071.
47. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
48. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
49. Swiecki M., Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 2010, 234:142-162.
50. Toyama-Sorimachi N., Tsujimura Y., Maruya M., Onoda A., Kubota T., Koyasu S., Inaba K., Karasuyama H. Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc. Natl. Acad. Sci. USA 2004, 101:1016-1021.
51. Tsujimura H., Tamura T., Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J.Immunol. 2003, 170:1131-1135.
52. Varol C., Vallon-Eberhard A., Elinav E., Aychek T., Shapira Y., Luche H., Fehling H.J., Hardt W.D., Shakhar G., Jung S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
53. Waskow C., Liu K., Darrasse-Jèze G., Guermonprez P., Ginhoux F., Merad M., Shengelia T., Yao K., Nussenzweig M. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 2008, 9:676-683.
54. Watowich S.S., Liu Y.J. Mechanisms regulating dendritic cell specification and development. Immunol. Rev. 2010, 238:76-92.
55. Wilson A., Laurenti E., Oser G., van der Wath R.C., Blanco-Bose W., Jaworski M., Offner S., Dunant C.F., Eshkind L., Bockamp E., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118-1129.
56. Zhang J., Raper A., Sugita N., Hingorani R., Salio M., Palmowski M.J., Cerundolo V., Crocker P.R. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 2006, 107:3600-3608.